Showing 181 - 200 results of 208 for search '"University of Gothenburg"', query time: 0.07s Refine Results
  1. 181
  2. 182
  3. 183
  4. 184

    Hydrophobic and Hydrophilic IOLs in Patients with Uveitis – A Randomised Clinical Trial by Pålsson S, Schuborg C, Sterner B, Andersson Grönlund M, Zetterberg M

    Published 2025-02-01
    “…Sara Pålsson,1,2 Claes Schuborg,2,3 Bertil Sterner,1,2 Marita Andersson Grönlund,1,4 Madeleine Zetterberg1,2 1Department of Clinical Neuroscience/Ophthalmology, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; 2Region Västra Götaland, Sahlgrenska University Hospital, Department of Ophthalmology, Mölndal, Sweden; 3Guldhedskliniken, Gothenburg, Sweden; 4Department of Ophthalmology, Faculty of Medicine and Health, Örebro University, Örebro, SwedenCorrespondence: Madeleine Zetterberg, Sahlgrenska University Hospital, Department of Ophthalmology, Mölndal, SE 431 80, Sweden, Tel +46 31 33 43 31 50, Fax +46 31 41 29 04, Email madeleine.zetterberg@vgregion.sePurpose: To compare inflammatory response, visual acuity, and complications of two intraocular lenses (IOLs) in patients with and without uveitis.Setting: Tertiary referral centre at Sahlgrenska University Hospital/Mölndal, Sweden.Design: Prospective randomised controlled trial.Patients and Methods: Patients with and without uveitis eligible for cataract surgery were randomised to receive a hydrophobic or a hydrophilic square-edged intraocular lens (IOL). …”
    Get full text
    Article
  5. 185
  6. 186
  7. 187
  8. 188
  9. 189
  10. 190
  11. 191
  12. 192
  13. 193
  14. 194
  15. 195
  16. 196
  17. 197

    Prevalence of Myocardial Infarction With Obstructive and Non-Obstructive Coronary Arteries in a Middle-Aged Population With Chronic Airflow Limitation: A Cross-Sectional Study by Sundh J, Ekström M, Blomberg A, Lindberg E, Malinovschi A, Olin AC, Sköld CM, Torén K, Wollmer P, Östgren CJ, Jernberg T

    Published 2025-02-01
    “…Josefin Sundh,1 Magnus Ekström,2 Anders Blomberg,3 Eva Lindberg,4 Andrei Malinovschi,5 Anna-Carin Olin,6 C Magnus Sköld,7,8 Kjell Torén,6 Per Wollmer,6 Carl Johan Östgren,9,10 Tomas Jernberg11,12 1Department of Respiratory Medicine, Faculty of Medicine and Health, Örebro University, Örebro, Sweden; 2Lund University, Faculty of Medicine, Department of Clinical Sciences Lund, Respiratory Medicine, Allergology and Palliative Medicine, Lund, Sweden; 3Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden; 4Department of Medical Sciences, Respiratory, Allergy and Sleep Research, Uppsala University, Uppsala, Sweden; 5Department of Medical Sciences, Clinical Physiology, Uppsala University, Uppsala, Sweden; 6Occupational and Environmental Medicine, School of Public Health and Community Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; 7Respiratory Medicine Unit, Department of Medicine Solna and Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden; 8Department of Respiratory Medicine and Allergy, Karolinska University Hospital, Stockholm, Sweden; 9Department of Translational Medicine, Lund University, Malmö, Sweden; 10Centre of Medical Image Science and Visualization (CMIV), Linköping University, Linköping, Sweden; 11Department of Health, Medicine and Caring Sciences, Linköping University, Linköping, Sweden; 12Department of Clinical Sciences, Danderyd Hospital, Karolinska Institutet, Stockholm, SwedenCorrespondence: Josefin Sundh, Department of Respiratory Medicine, Faculty of Medicine and Health, Örebro University, Örebro, 701 82, Sweden, Tel +46702349517, Email josefin.sundh@regionorebrolan.se; josefin.sundh@oru.sePurpose: Myocardial infarctions (MIs) can occur in underlying obstructive coronary artery disease (MI-CAD) or in non-obstructive coronary arteries (MINOCA). …”
    Get full text
    Article
  18. 198
  19. 199
  20. 200